Skip to main content
Official Website of Stem Cell Mexico – Since 2002
Stem Cell Therapy Mexico

How does stem cell therapy work?

Stem cell therapy with mesenchymal stem cells (MSCs) works through communication rather than replacement.

Free Consultation

Instead of turning into large amounts of new tissue, MSCs act like a temporary "signaling center": they sense inflammation and injury and release growth factors, anti-inflammatory molecules and tiny packages called extracellular vesicles, or exosomes, that instruct the body's own cells to calm inflammation, protect damaged tissue, form new small blood vessels and activate repair. This is known as paracrine signaling. MSCs also modulate the immune system, helping shift it from a damaging, inflammatory state toward a more balanced, healing state. At Stem Cell Mexico, treatment uses only allogeneic MSCs from Wharton's jelly of the umbilical cord, applied by direct injection into the area that needs it or by intravenous (IV) infusion for systemic goals. The effects develop over weeks to months, and results vary between patients.

This guide explains, in plain language, what MSCs are, what they do in the body, how the route of application changes their effect and why results are gradual.

What mesenchymal stem cells are

Stem cells are cells that can renew themselves and give rise to specialized cells. According to the National Institutes of Health (NIH), there are different types, including embryonic stem cells, blood-forming stem cells and adult stem cells found in various tissues.

MSCs are adult stromal cells found in tissues such as bone marrow, fat and the umbilical cord. The International Society for Cell and Gene Therapy (ISCT) defines them by specific laboratory criteria: they attach to plastic surfaces in culture, carry certain surface markers and can become bone, cartilage and fat cells in the laboratory. In the body, however, their main value lies in the signals they send.

Why Wharton's jelly

Wharton's jelly is the gel-like tissue inside the umbilical cord. MSCs from this tissue are young, grow well in the laboratory, have strong signaling activity and are obtained from donated cords after healthy births, without any procedure for the patient. They also express very low levels of the molecules that trigger strong immune rejection, which is why they can be used without tissue matching.

What MSCs do in the body

1. Calm inflammation

Chronic inflammation drives pain and damage in many conditions, from osteoarthritis to neurological and cardiovascular disease. MSCs release anti-inflammatory factors and encourage immune cells to shift from an inflammatory to a repair-oriented state.

2. Modulate the immune system

MSCs interact with several types of immune cells, helping restore balance in conditions where the immune response is overactive. This is why they are studied in autoimmune and inflammatory conditions.

3. Protect cells

Trophic factors released by MSCs help stressed cells survive, including nerve cells, heart cells and cartilage cells.

4. Support new blood vessels

MSCs promote the formation of small blood vessels, improving the supply of oxygen and nutrients to damaged tissue.

5. Limit scarring

By influencing fibroblasts, the cells that produce scar tissue, MSCs may reduce excessive fibrosis.

6. Activate the body's own repair cells

MSC signals can stimulate local progenitor cells in the tissue to participate in repair.

The role of exosomes

Exosomes are tiny vesicles released by MSCs that carry proteins, lipids and genetic messages to other cells. They are one of the main ways MSCs communicate. Some protocols use exosomes derived from umbilical cord MSCs on their own, for example in hair, skin or hearing protocols, because they deliver concentrated signals without whole cells.

How the route of application changes the effect

A review in Frontiers in Immunology describes how the route of delivery determines where MSCs go and how long they stay:

  • Direct injection into a joint, tendon, disc or other tissue places cells exactly where they are needed. Image guidance with ultrasound or fluoroscopy improves precision. This is the main route for musculoskeletal problems.
  • IV infusion distributes cells and their signals throughout the body. Many cells pass through the lungs first, and their effects are largely systemic, through circulating signals and interactions with the immune system. This route is used for neurological, cardiovascular, metabolic and healthy aging goals.
  • Intrathecal application, into the fluid around the spinal cord, places cells closer to the nervous system and is used in selected neurological cases.

Why results are gradual

MSCs do not stay in the body permanently. They deliver their signals over days to weeks and are then gradually cleared. The changes they trigger, such as reduced inflammation, tissue protection and repair, continue to develop afterward. This is why many patients notice improvement over weeks to months rather than immediately, and why rehabilitation and healthy habits help turn those changes into lasting function.

What MSCs do not do

  • They do not transform into whole new organs or replace large amounts of tissue that has been lost over years.
  • They do not stay in the body indefinitely; they deliver their signals and are gradually cleared.
  • They do not work the same way in every condition or every person, because the environment they act on is different.

Understanding this helps set realistic expectations: the goal is to improve how tissues function and how you feel, not to rebuild the body.

An everyday comparison

A useful way to picture MSCs is to think of a construction site after a storm. The workers who rebuild are already there: your own cells. What MSCs bring is coordination. They arrive, assess the situation, calm the chaos, call in the right teams, make sure supplies arrive through new small roads (blood vessels) and leave once the work is under way. The rebuilding continues after they leave, which is why improvement keeps developing for weeks and months.

Why the same cells can help different conditions

Many chronic conditions share common processes: persistent inflammation, an imbalanced immune response, poor blood supply and cells under stress. Because MSCs act on these shared processes, the same cell type can be used for very different goals, from a painful knee to recovery after a stroke. What changes is the route, the number of cells and the plan around the treatment, such as rehabilitation for joints and neurological conditions or medical follow-up for heart and kidney conditions.

Factors that influence how well MSCs work

  • The condition and its stage: more remaining healthy tissue means more opportunity to respond.
  • The route and precision: placing cells where they are needed, with image guidance when applicable.
  • The number of cells: chosen for the target, the route and your body weight.
  • The environment: controlled blood sugar, blood pressure and weight, no smoking and good sleep support repair.
  • Activity and rehabilitation: movement and therapy help convert reduced inflammation into better function.
  • Certain medications: anti-inflammatory painkillers and recent cortisone injections are reviewed, since they can affect the treatment.

What the evidence shows

  • Knee osteoarthritis: a 2024 meta-analysis of randomized trials in the Journal of Orthopaedic Translation found that MSC injections reduced pain more than hyaluronic acid at 12 months and improved function.
  • Safety: a 2026 meta-analysis of IV umbilical-cord-derived MSCs in Stem Cells Translational Medicine found temporary fever as the most consistent side effect, without an increase in serious infection, thrombosis, cancer or death.

How the cells are prepared

The cells used at Stem Cell Mexico come from the Wharton's jelly of donated umbilical cords, obtained after healthy, full-term births with the mother's informed consent and donor screening. They are isolated and expanded in a COFEPRIS-licensed laboratory under Good Manufacturing Practice standards, with quality and safety testing before release, and prepared for your scheduled treatment date.

What our patients usually receive

Based on the treatment plans our team prepares, typical protocols include:

  • For joints or the spine: 20 to 40 million cells per area by direct injection with image guidance, often with platelet-rich plasma (PRP).
  • For systemic and neurological goals: IV infusion, usually 100 to 200 million cells, and in selected neurological cases an additional intrathecal application.
  • One night at our facilities, the consultation with your doctor and the stem cell specialist, and ground transportation from the San Diego airport area.

Questions to ask during your evaluation

  • How would MSCs act in my specific condition?
  • Which route would be used, and why?
  • When could I expect to notice changes?
  • How many cells are recommended for me, and how is that number chosen?
  • What can I do to support the effect of the cells?

Bottom line

Stem cell therapy with MSCs works mostly through signals: the cells calm inflammation, modulate the immune system, protect cells, support new blood vessels and activate the body's own repair, with effects that develop over weeks to months. At Stem Cell Mexico, Wharton's jelly MSCs are applied locally or by IV infusion according to your goal, and results vary between patients. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your condition, goals and medical history.

References

  1. National Institutes of Health (NIH): Stem cell basics (opens in a new tab)
  2. Viswanathan S et al. Mesenchymal stem versus stromal cells: International Society for Cell and Gene Therapy (ISCT) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy, 2019 (opens in a new tab)
  3. Caplan H, Olson SD, Cox CS Jr et al. Mesenchymal stromal cell therapeutic delivery: translational challenges to clinical application. Frontiers in Immunology, 2019 (opens in a new tab)
  4. Tabet CG et al. Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Translation, 2024 (opens in a new tab)
  5. Hum C et al. Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis. Stem Cells Translational Medicine, 2026 (opens in a new tab)

Request your medical evaluation

A clearer path starts here.

Tell us a little about yourself. We’ll help you understand the next step.

Vania, patient coordinator at Stem Cell Mexico

Vania, our patient coordinator

Your questions. Your travel plans.
A real person to help.

Talk to Vania on WhatsApp (opens in a new tab)

What happens next?

  1. Your advisor contacts you.
  2. We explain the medical review.
  3. You explore your options.

Call +1 800 646 0290

Let’s begin with you.

Your inquiry starts a conversation. Treatment requires medical evaluation.

Vania · Patient Advisor

Start my free evaluation
Free Consultation